Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,358,776
+$9,607,847 QoQ
Shares Held
560,282
+0.3% QoQ
Ownership
0.334%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#53
of 423 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $232,519,537 across 16 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,189,584 | $40,303,105 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
1,612,986 | $39,695,585 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
708,276 | $32,941,916 | |
| 4 | ALKS |
Alkermes plc.
This page
|
560,282 | $29,358,776 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
359,721 | $17,004,011 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
846,387 | $15,201,110 | |
| 7 | VTRS |
Viatris Inc
|
803,143 | $12,753,910 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
23,074 | $12,502,185 |
All Filings in ALKS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,358,776 | 560,282 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,750,929 | 558,567 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,628,704 | 558,567 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $16,757,010 | 558,567 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,977,683 | 558,465 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,566,880 | 744,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,360,512 | 742,716 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,759,623 | 741,680 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,812,811 | 1,071,071 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $28,960,568 | 1,069,840 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,474,912 | 1,170,689 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,790,998 | 1,170,689 | Shares | Sole | 2023-11-14 | |
| 2022-06-30 | $55,315,472 | 1,856,847 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,582,021 | 1,314,406 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $37,653,404 | 1,618,805 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $30,776,993 | 997,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $24,469,734 | 997,950 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,280,740 | 871,560 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $42,720,311 | 2,141,369 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $35,880,200 | 1,848,542 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||